As aging research remains at the forefront of biomedical science and an increasingly growing social issue, understanding the biological mechanisms behind cellular and organismal decline is crucial to extending healthspan — the period of life spent in good health — and overall lifespan. Despite the need to accelerate the discovery of preventive aging interventions, traditional methods depending on manual work face limitations that hinder scalability, increase costs, and slow progress toward actionable outcomes.
To address these challenges, Nagi Bioscience has developed an innovative platform that integrates the biological relevance of in vivo testing with the scalability of in vitro systems, offering actionable insights into the effects of various interventions on aging pathways, all while maintaining ethical standards.
By providing a streamlined solution for testing and evaluating a wide range of compounds, Nagi Bioscience accelerates the discovery and de-risking of potential therapeutics that can enhance healthspan, mitigate age-related decline, and ultimately contribute to a longer, healthier life.